The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.
about
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational ProspectiveCardiac biomarkers: new tools for heart failure managementCan biomarkers help to diagnose early heart failure with preserved ejection fraction?The association of growth differentiation factor-15 with left ventricular hypertrophy in hypertensive patients.Emerging biomarkers in heart failure and cardiac cachexiaElevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study.Inflammation and cardiac outcomeNatriuretic peptides for the detection of paroxysmal atrial fibrillation.Growth-differentiation factor-15 and functional outcome after acute ischemic stroke.GDF 15--A Novel Biomarker in the Offing for Heart Failure.Integrating the myocardial matrix into heart failure recognition and management.Plasma growth differentiation factor 15 predicts first-ever stroke in hypertensive patients.Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside.Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.Growth/differentiation factor-15: prostate cancer suppressor or promoter?Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.Growth differentiation factor 15 in heart failure: an update.Clinical use of novel biomarkers in heart failure: towards personalized medicine.Biomarkers of heart failure with normal ejection fraction: a systematic review.Diagnosing heart failure with preserved ejection fraction.Pathophysiology of diastolic dysfunction in chronic heart failure.Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches?Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity.Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.The future diagnosis of heart failure with normal ejection fraction: less imaging, more biomarkers?
P2860
Q26798142-D6957D65-C8AC-48C9-99A8-5E35B5A193C9Q26991726-00F09BD7-3124-4DBE-85E3-22EDE22A308CQ28087822-9B9A6C99-AAC2-4E29-A4A2-E31C84343A42Q34447208-0FCDAAD4-9077-4C9F-8BDA-FE65913EAECBQ34836097-4CA1E8C8-911D-4216-B6C5-FBDFFD3EABF2Q35760339-7AEECBDE-34AF-431D-9D92-CEA72752FEB8Q35835539-2F48FB2E-7E37-4345-A3CB-038789542C56Q35942924-D4AD5065-CC14-4962-ADE6-715726904D60Q36133676-815BB0E6-C9AD-40CA-9E97-3BA6AAE49777Q36728674-286CD7F2-D11C-4C6A-9B5D-CBA546D3914BQ37406111-015FBB1B-AD91-4C11-926B-3D138F417501Q37605661-57CD1339-72AD-4B08-BA20-93C7C4056493Q37896086-790DE62D-7363-4BBA-A17F-3F5FCEC0CBD1Q37970489-3C178776-AA7C-4ED1-92A4-23C8B43CE412Q37988746-2D1220BD-E7B1-4BBD-981A-34612B6032A1Q37993133-257868A8-0F19-45BC-B586-C53B8C12B5B6Q38041973-7A589023-8FD4-45FE-BAE8-1704E5A81516Q38109588-99268F2D-2244-4BFB-A86E-78998CC98B02Q38120919-F4D8EDC3-921C-44A2-B447-0AF404CA8B72Q38127754-413E45EF-BB8A-41B3-8BFD-E57FC4898C77Q38135894-DB8742BF-ED9A-433F-BFBD-077D3A88CCD8Q38223600-F4DC53FB-C6A5-41C4-A581-0FF54FC8F1D6Q38245545-62610116-4B01-4426-8BAE-7AA7F33A5A51Q38427211-883D236E-8D69-48E4-A2AC-14ED1BA33771Q38790569-645912B6-34CE-4505-8350-EDE849758793Q39127729-E0C6EF68-38C7-47B1-A707-61E493F35FEBQ40396855-101E59DE-B291-445F-9BE6-467B8D8BDED8Q44871151-09B06FDA-D26E-4333-81C5-C050170105BBQ46469495-F19B3050-8956-4623-9D01-DFAF803642B2Q47747440-DFEA2318-6781-4F37-A15C-6D61A3282B7FQ48725493-E1382912-78D4-45C7-B93B-B9946337997AQ51687690-118805A9-68D1-4C6A-B0B4-479200148B40
P2860
The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The novel biomarker growth dif ...... with normal ejection fraction.
@ast
The novel biomarker growth dif ...... with normal ejection fraction.
@en
The novel biomarker growth dif ...... with normal ejection fraction.
@nl
type
label
The novel biomarker growth dif ...... with normal ejection fraction.
@ast
The novel biomarker growth dif ...... with normal ejection fraction.
@en
The novel biomarker growth dif ...... with normal ejection fraction.
@nl
prefLabel
The novel biomarker growth dif ...... with normal ejection fraction.
@ast
The novel biomarker growth dif ...... with normal ejection fraction.
@en
The novel biomarker growth dif ...... with normal ejection fraction.
@nl
P2093
P2860
P50
P356
P1476
The novel biomarker growth dif ...... with normal ejection fraction.
@en
P2093
Anke Kockskämper
Claus Lüers
Frank Edelmann
Götz Gelbrich
Hans-Dirk Düngen
Lutz Binder
Meinhard Mende
Raoul Stahrenberg
Rolf Wachter
P2860
P304
P356
10.1093/EURJHF/HFQ151
P577
2010-09-13T00:00:00Z